DE69730476D1 - Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen - Google Patents

Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen

Info

Publication number
DE69730476D1
DE69730476D1 DE69730476T DE69730476T DE69730476D1 DE 69730476 D1 DE69730476 D1 DE 69730476D1 DE 69730476 T DE69730476 T DE 69730476T DE 69730476 T DE69730476 T DE 69730476T DE 69730476 D1 DE69730476 D1 DE 69730476D1
Authority
DE
Germany
Prior art keywords
albumin
treatment
constal
present
active component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69730476T
Other languages
English (en)
Other versions
DE69730476T2 (de
Inventor
Kazuo Tsubota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DE69730476D1 publication Critical patent/DE69730476D1/de
Publication of DE69730476T2 publication Critical patent/DE69730476T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69730476T 1996-04-19 1997-04-17 Albumin als aktiver Bestandteil zur Behandlung von Bindehaut- und Hornhautverletzungen und von trockenen Augen Expired - Lifetime DE69730476T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP9809096 1996-04-19
JP9809096 1996-04-19
JP10686696 1996-04-26
JP10686696 1996-04-26
US75294196A 1996-11-21 1996-11-21
US75292896A 1996-11-21 1996-11-21
US752941 1996-11-21
US752928 1996-11-21
PCT/JP1997/001329 WO1997039769A1 (fr) 1996-04-19 1997-04-17 Composition de medicament comprenant de l'albumine en tant que principe actif

Publications (2)

Publication Number Publication Date
DE69730476D1 true DE69730476D1 (de) 2004-10-07
DE69730476T2 DE69730476T2 (de) 2005-11-17

Family

ID=27468604

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69730476T Expired - Lifetime DE69730476T2 (de) 1996-04-19 1997-04-17 Albumin als aktiver Bestandteil zur Behandlung von Bindehaut- und Hornhautverletzungen und von trockenen Augen

Country Status (11)

Country Link
US (2) US6043213A (de)
EP (1) EP0834320B1 (de)
JP (1) JP3058920B2 (de)
KR (1) KR100455475B1 (de)
CN (1) CN1124158C (de)
AT (1) ATE274918T1 (de)
CA (1) CA2225398C (de)
DE (1) DE69730476T2 (de)
ES (1) ES2227684T3 (de)
NO (1) NO320601B1 (de)
WO (1) WO1997039769A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815419B1 (en) 1999-07-28 2004-11-09 Morinaga Milk Industry Co., Ltd. Antiulcer agent
GB0019378D0 (en) * 2000-08-07 2000-09-27 Saugstad Ola D Method
DE60224857T2 (de) * 2001-04-26 2009-02-05 R-Tech Ueno, Ltd. Verwendung von Albumin in Kombination mit Wachstumsfaktoren zur Inhibierung von Apoptose
US20030211043A1 (en) * 2001-09-28 2003-11-13 Korb Donald R. Eye treatment
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US7189697B2 (en) * 2004-04-13 2007-03-13 Trustees Of Tufts College Compositions and uses of a galectin for treatment of dry eye syndrome
US20060232060A1 (en) * 2005-04-13 2006-10-19 Assignee1 Pressure sensitive packing laminate overlay form combination and method of using same
WO2007033020A2 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation for treatment of dry eye
US20080286211A1 (en) * 2007-04-27 2008-11-20 Barker Nicholas P Using mucin glycoproteins in combination with therapeutic agents to treat epithelial lesions and disorders of impaired mucin function
US20110065642A1 (en) 2008-05-15 2011-03-17 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
KR101422571B1 (ko) 2009-10-13 2014-07-24 삼성전자 주식회사 받침대 및 이를 구비한 세탁기
AU2013203609B2 (en) * 2009-11-27 2014-08-21 R-Tech Ueno, Ltd. Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
BR112012012767A2 (pt) * 2009-11-27 2016-09-06 R Tech Ueno Ltd método para avaliar um agente que é útil para o tratamento de olho seco e/ou lesão corneana e conjutiva e uma composição farmacêutica obtida pelo método
AU2011347237A1 (en) * 2010-12-21 2013-07-11 Recopharma Ab Tear substitutes
DE102015205293A1 (de) 2015-03-24 2016-09-29 Marc Schrott Verfahren zur Herstellung von Augentropfen
KR102368465B1 (ko) * 2016-04-01 2022-03-02 주식회사 바이오코즈글로벌코리아 세포배양배지에 알부민, 히알루론산, 또는 콜라겐을 유효성분으로 포함하는 화장용 조성물
CA3092234A1 (en) 2018-03-09 2019-09-12 Panoptes Pharma Ges.M.B.H. Ophthalmic formulation
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
BR112021000724A2 (pt) 2018-07-27 2021-04-13 Johnson & Johnson Surgical Vision, Inc. Composições e métodos para tratar os olhos
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57126422A (en) * 1981-01-29 1982-08-06 Green Cross Corp:The Stabilizing method of lysozyme pharmaceutical
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
WO1990011781A1 (en) * 1989-04-04 1990-10-18 Alcon Laboratories, Inc. The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JPH05310592A (ja) * 1992-05-11 1993-11-22 Nichirei Corp 創傷治療剤及び医薬製剤
JPH06271478A (ja) * 1993-03-23 1994-09-27 Otsuka Pharmaceut Co Ltd ドライアイ治療剤
EP0637450A3 (de) * 1993-08-04 1995-04-05 Collagen Corp Verfahren und Zusammensetzung zur Wiederbelebung von Nerbgewebe.
US6013628A (en) * 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides

Also Published As

Publication number Publication date
ES2227684T3 (es) 2005-04-01
EP0834320B1 (de) 2004-09-01
ATE274918T1 (de) 2004-09-15
EP0834320A1 (de) 1998-04-08
US6043213A (en) 2000-03-28
DE69730476T2 (de) 2005-11-17
KR100455475B1 (ko) 2004-12-17
NO320601B1 (no) 2005-12-27
CN1195296A (zh) 1998-10-07
CN1124158C (zh) 2003-10-15
EP0834320A4 (de) 2000-11-22
CA2225398A1 (en) 1997-10-30
NO975962D0 (no) 1997-12-18
JP3058920B2 (ja) 2000-07-04
US6159930A (en) 2000-12-12
WO1997039769A1 (fr) 1997-10-30
NO975962L (no) 1998-02-18
CA2225398C (en) 2008-07-15
KR19990028235A (ko) 1999-04-15

Similar Documents

Publication Publication Date Title
DE69730476D1 (de) Albumin als aktiven bestandteil zur behandlung von bindehaut- und hornhautverletzungen und von trockenen augen
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
ATE480240T1 (de) Zusammensetzung enthaltend latanoprost und behandlungsmethode von erhöhtem augeninnendruck und glaukom
DE60022544D1 (de) Behandlung von augenerkrankungen
ID29257A (id) Penghambat-penghambat protease dalam benda-benda penyerap
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
PT1040830E (pt) Medicamento para doencas neurodegenerativas
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE60231131D1 (de) Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
NO933140D0 (no) Legemiddel for lokal anvendelse paa oeyet for behandling avforhoeyet intraokulart trykk
EP0667160A3 (de) Anwendung von Prostagrandin-Analogen für die Behandlung von Glaukome und okuläre Hypertension.
ATE112960T1 (de) Anthocyanidine zur behandlung von augenkrankheiten.
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
DE69921678D1 (de) Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
EP0453337A3 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use
RU97116792A (ru) Способ лечения эрозий роговицы после эксимерлазерной фоторефракционной кератэктомии
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: TSUBOTA, KAZUO, FUNABASHI, CHIBA, JP

Owner name: SUCAMPO AG, ZUG, CH

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH

Owner name: R-TECH UENO, LTD., TOKYO, JP